Establishes Assembly Select Committee on COVID-19 Contact Tracing Data Privacy.
Impact
The resolution mandates that the committee, consisting of nine members appointed by both the Speaker and Minority Leader of the General Assembly, will produce a report within 60 days of its formation. This report will outline findings and recommendations aimed at enhancing the security and privacy protocols concerning the collection and use of contact tracing data. By establishing this committee, AR32 envisions creating a regulatory framework that addresses public health concerns while safeguarding personal health information. This could lead to legislative actions that protect citizens' rights amid the expansion of data collection during health emergencies.
Summary
Assembly Resolution AR32 establishes the Assembly Select Committee on COVID-19 Contact Tracing Data Privacy in New Jersey. This committee is tasked with examining the implications of data collected during contact tracing activities in response to the COVID-19 pandemic. Specifically, the committee will address issues related to data privacy, potential misuse, and compliance with existing federal regulations such as the Health Insurance Portability and Accountability Act (HIPAA). Through this resolution, the Assembly underscores the need for balancing effective contact tracing with the protection of individuals' privacy rights.
Contention
One notable point of contention surrounding AR32 is the dual necessity of effective contact tracing as a public health strategy against the spread of COVID-19, set against the backdrop of protecting individuals' right to privacy. Advocates for data privacy argue that without clear guidelines and responsibilities, there exists a risk of data misuse, which could lead to violations of personal privacy. The formation of the committee is seen as a step towards addressing these concerns and providing a structured approach to data management in the context of health crises.
Restricts establishment of mandates to become vaccinated against coronavirus disease 2019 (COVID-19); establishes reimbursement program to cover certain out-of-pocket costs incurred in obtaining COVID-19 vaccine.
Limits for contact tracing, digital contract tracing, immunizations, communicable disease testing, and the required disclosure of certain information established; destruction of certain data required; mandatory digital contact tracing by employers prohibited; and civil penalties provided.
Establishes matching grant program in DOE for school districts to implement high-impact tutoring programs addressing learning loss due to COVID-19 pandemic.